Enhancing Base Excision Repair of Mitochondrial DNA to Reduce Ischemic Injury Following Reperfusion

Area of Science:

• Neuroscience
• Molecular Biology
• Cardiovascular Research

Background:

• Ischemic stroke leads to significant brain damage, often exacerbated by reperfusion injury.
• Mitochondrial DNA damage and impaired base excision repair (BER) contribute to post-stroke injury.
• Current treatments aim to restore blood flow but can worsen injury through reperfusion.

Purpose of the Study:

• To investigate if enhancing mitochondrial base excision repair (BER) capability can mitigate reperfusion-associated ischemic brain injury.
• To evaluate the neuroprotective potential of a specific DNA glycosylase, EndoIII, in a mouse model of stroke.

Main Methods:

• Transient middle cerebral artery occlusion (MCAO) for 60 minutes was used to model ischemic stroke and reperfusion in mice.
• A TAT-modified DNA glycosylase (EndoIII) was administered intravenously following reperfusion.
• Brain infarct volume was measured to assess the protective effects of EndoIII treatment.

Main Results:

• Administration of EndoIII significantly reduced brain infarct volume in a dose-dependent manner.
• The protective effect was specific to BER enzymes and showed regional specificity, being more effective via the jugular vein.
• EndoIII demonstrated compatibility with tissue plasminogen activator (tPA) and had a therapeutic time window of 3 hours post-reperfusion.

Conclusions:

• Enhancing mitochondrial BER capacity represents a novel therapeutic strategy against ischemic brain injury.
• EndoIII offers a promising neuroprotective approach for patients undergoing revascularization procedures after stroke.
• This finding supports the development of adjunct therapies to improve outcomes in stroke treatment.